title: Pre-clinical study on tumor vasoactive intestinal peptide receptor scintigraphy.
abstract: OBJECTIVE
  To develop a tumor imaging agent for vasoactive intestinal peptide (VPAC) receptor and evaluate its biological activity and pharmacokinetics of radiolabeled peptide.
  
  
  METHODS
  VIP(28) was modified at the carboxyl terminal by the addition of His-tag which was the chelating site of (99m)Tc(I) and the general purification tag for immobilized metal ion affinity chromatography. Biological activity of the modified VIP(28) analogue MY34 was examined in vitro by radiological cell-binding assay, rabbit internal anal sphincter (IAS) smooth muscle relaxing assay and immunocytochemical stain. The pharmacokinetics of this labeled peptide was examined in C57 mice.
  
  
  RESULTS
  MY34 could relax the IAS smooth muscle and bind VPAC receptors on tumor cell membranes. (99m)Tc- MY34, with a yield of about 90%, was stable enough for practical use. Both MY34 and VIP(28) could inhibit the binding between the labeled peptide and VPAC receptor. The pharmacokinetics of [(99m)Tc(H(2)O)(3)(CO)(3)]-MY34 was studied in mice conformed well with the two-compartment model (Wi = 1/C(2)), with a t(1)/(2alpha) of 16.35 min and a t(1)/(2beta) of 1013.56 min.
  
  
  CONCLUSIONS
  MY34 possesses physiological activities and specific receptor binding characteristics similar to those of natural VIP(28).
authors.affiliation: Peking University School of Oncology, Beijing Institute for Cancer Research, Beijing Cancer Hospital, Beijing 100036, China.
authors.forename: Xuejuan
authors.initials: X
authors.lastname: Wang
authors.forename: Meiying
authors.initials: M
authors.lastname: Zhang
authors.forename: Zhi
authors.initials: Z
authors.lastname: Yang
authors.forename: Baohe
authors.initials: B
authors.lastname: Lin
authors.forename: Qingyun
authors.initials: Q
authors.lastname: Zhang
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001667:Binding, Competitive; D007553:Isotope Labeling; D051379:Mice; D008810:Mice, Inbred C57BL; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D015609:Organotechnetium Compounds; D010455:Peptides / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D011817:Rabbits; D011877:Radionuclide Imaging; D018005:Receptors, Vasoactive Intestinal Peptide / Q000032:analysis*; D013274:Stomach Neoplasms; D014407:Tumor Cells, Cultured; D014660:Vasoactive Intestinal Peptide / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology
chemical_list: D015609:Organotechnetium Compounds; D010455:Peptides; D018005:Receptors, Vasoactive Intestinal Peptide; D014660:Vasoactive Intestinal Peptide